Steven Lin
founderYC
Specializes inArtificial Intelligence
Cofounder and CTO at FinalDose (YC P26). Oxford PhD in Computational Biology with Wellcome Trust full scholarship. Previously Data Lead at Gutsee Biotech. Developed novel machine learning method to use coevolution biology to identify genetic targets that convey drug resistance in viruses. During SARS-CoV-2 pandemic, led UK biobank analysis of human genetics susceptibility for infections
1
product
Products · 1
Worked alongside
Roles are derived from products, launches and repositories we track — not from self-description.